Latiglutenase as a Treatment for Celiac Disease
Condition: Celiac Disease Intervention: Drug: Latiglutenase Sponsors: Immunogenics, LLC; National Institutes of Health (NIH); National Center for Complementary and Integrative Health (NCCIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Celiac Disease | Coeliac Disease